Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia
Author(s)
Rahman, Sunniyat; Magnussen, Michael; León, Theresa E.; Farah, Nadine; Li, Zhaodong; Alapi, Krisztina Z.; Mitchell, Rachel J.; Naughton, Tom; Fielding, Adele K.; Pizzey, Arnold; Bustraan, Sophia; Popa, Teodora; Pike-Overzet, Karin; Garcia-Perez, Laura; Gale, Rosemary E.; Linch, David C.; Staal, Frank J. T.; Look, A. Thomas; Mansour, Marc R.; Abraham, Brian Joseph; Allen, Christopher D; Young, Richard A.; ... Show more Show less
DownloadRahman et al_2017_Somatically acquired activation of LMO2 in T-ALL.pdf (2.530Mb)
OPEN_ACCESS_POLICY
Open Access Policy
Creative Commons Attribution-Noncommercial-Share Alike
Terms of use
Metadata
Show full item recordAbstract
Somatic mutations within noncoding genomic regions that aberrantly activate oncogenes have remained poorly characterized. Here we describe recurrent activating intronic mutations of LMO2, a prominent oncogene in T-cell acute lymphoblastic leukemia (T-ALL). Heterozygous mutations were identified in PF-382 and DU.528 T-ALL cell lines in addition to 3.7% of pediatric (6 of 160) and 5.5% of adult (9 of 163) T-ALL patient samples. The majority of indels harbor putative de novo MYB, ETS1, or RUNX1 consensus binding sites. Analysis of 5′-capped RNA transcripts in mutant cell lines identified the usage of an intermediate promoter site, with consequential monoallelic LMO2 overexpression. CRISPR/Cas9-mediated disruption of the mutant allele in PF-382 cells markedly downregulated LMO2 expression, establishing clear causality between the mutation and oncogene dysregulation. Furthermore, the spectrum of CRISPR/Cas9-derived mutations provides important insights into the interconnected contributions of functional transcription factor binding. Finally, these mutations occur in the same intron as retroviral integration sites in gene therapy–induced T-ALL, suggesting that such events occur at preferential sites in the noncoding genome.
Date issued
2016-09Department
Massachusetts Institute of Technology. Department of BiologyJournal
Blood
Publisher
American Society of Hematology
Citation
Rahman, Sunniyat, Michael Magnussen, Theresa E. León, Nadine Farah, Zhaodong Li, Brian J. Abraham, Krisztina Z. Alapi, et al. “Activation of the LMO2 Oncogene through a Somatically Acquired Neomorphic Promoter in T-Cell Acute Lymphoblastic Leukemia.” Blood 129, no. 24 (March 7, 2017): 3221–3226.
Version: Author's final manuscript
ISSN
0006-4971
1528-0020